A Post Marketing Evaluation of the Safety of FluMist in Children 24-59 Months of Age in a Managed Care Setting
24 Months - 59 Months
Endpoint Classification: -
Intervention Model: Single Group Assignment
Masking: Open Label
Primary Purpose: -
Verified 01 Mar 2012 by MedImmune, LLC
No locations available
|Active Comparator: 2|
Biological/Vaccine: TIV (Injection)
One or two injections of TIV depending on previous status.
|Active Comparator: 1|
One or two vaccinations with FluMist depending on prior vaccination status.
|No Intervention: 3|
Other: Unvaccinated Control